Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients

Ellen J. Collarini, Lawrence M. Kauvar, Orit Foord et al.|The Journal of Immunology|2009

Cited by 96